What is it about?
Our study was designed in China to evaluate the efficacy and safety of RFA therapy combined with systemic CT in patients with solitary CRLM for CRC
Featured Image
Why is it important?
In China, where the mortality rate is high, there is an unmet need of large-scale studies to improve the OS in CRLM. To the best of our knowledge, this was the first long-term study conducted in China, which evaluated the efficacy and safety of ultrasound-guided RFA along with systemic CT and molecular-targeted therapy used in the treatment of solitary CRLM for CRC.
Perspectives
In a country like China, where the mortality rate is high, there is an unmet need of large-scale studies to improve the OS in this challenging area of cancer. Therefore, I hope our study would provide insights and create awareness for effective treatment in patients with solitary CRLM for RFA.
Shuangyan Ou
Hunan Cancer Hospital
Read the Original
This page is a summary of: Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study, Cancer Management and Research, October 2018, Dove Medical Press,
DOI: 10.2147/cmar.s170160.
You can read the full text:
Contributors
The following have contributed to this page
